ArticleActa pharmaceutica Sinica. B2025

Discovery of orally active and serine-targeting covalent inhibitors against hCES2A for ameliorating irinotecan-triggered gut toxicity.

Ya Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.